Wednesday, August 23, 2006

ADHD: FDA requires warning label on ADHD drug

From the CEC Smart Brief:

The U.S. Food and Drug Administration has asked GlaxoSmithKline to add a warning label to its prescription drug Dexedrine that states use of the stimulant has been linked to sudden death, heart problems and psychological side effects. An NYU psychiatrist notes that the caution, less severe than a black box warning, does not assume causality. Forbes /HealthDay News (free registration) (8/23)

No comments:

Promethean Planet


The following is the opinion of the writer and is not intended to malign any religion, ethnic group, club, organization, company, or individual. Any view or opinion represented in the blog comments are personal and is accredited to the respective commentor / visitor to this blog. This blogger reserves the right to moderate comment suitability in support of respecting racial, religious and political sensitivities, and in order to protect the rights of each commentor where available.